جست‌وجوی استاد و پژوهشگر

Eduardo E. Benarrochمشاهده پروفایل

استاد

• Neurodegenerative disorders
• Autonomic disorders
• Parkinson's disease
• +۳ مورد دیگر

Eduardo E. Benarroch, M.D., is a Professor of Neurology and Consultant in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. His research focuses on neurochemical mechanisms underlying neurodegenerative disorders such as multiple system atrophy (MSA) and Lewy body diseases, with emphasis on brainstem and hypothalamic neuronal groups controlling homeostasis. His work is supported by the MSA Coalition and has contributed to understanding autonomic, respiratory, and sleep symptom mechanisms in Parkinson's disease. Dr. Benarroch holds a D.Sci. in Physiology from Buenos Aires University and completed multiple fellowships including NIH Fogarty International Fellowship at Cornell University. He has held leadership roles including President of the American Autonomic Society and Co-Director of Mayo's Neuroscience Laboratory. His 286+ publications span neurochemical pathology, autonomic disorders, and clinical neurology. Awarded the AB Baker Lifetime Achievement Award in Neurologic Education, he has received repeated teaching honors including Mayo's Distinguished Educator Award. His professional memberships include American Academy of Neurology, Society for Neuroscience, and Sigma Xi. He has advised numerous trainees and contributed to consensus guidelines on dysphagia in neurodegenerative diseases.

Walter Struhalمشاهده پروفایل

دانشیار

• Neurology
• Autonomic Nervous System
• Alzheimer's Dementia
• +۴ مورد دیگر

Prim. Assoc. Prof. PD Dr. Walter Struhal MSc FEAN serves as Head of the Clinical Department of Neurology at University Hospital Tulln since 2017 and holds a shared leadership role at the University Clinic for Neurology (Karl Landsteiner Private University of Health Sciences) since 2019. His career bridges clinical neurology and translational research in autonomic nervous system disorders. Research Focus : Struhal specializes in autonomic dysfunction, particularly its role in Alzheimer's dementia, post-COVID-19 neurological sequelae, and neurodegenerative diseases like multiple system atrophy. His work emphasizes modern diagnostic tools such as wearable ECGs and power modulation spectrum algorithms for signal quality control. Recent collaborations include developing the NEUROGED Guidelines for neurogenic urinary/sexual symptoms and mapping autonomic education gaps in European neurology training. Scientific Contributions : As a Fellow of the European Academy of Neurology (FEAN) , he co-led international studies on ECG quality indices (PDQI/MSQI) and participated in the AFFRICATE Project analyzing autonomic impacts of cerebral vascular interventions. His 15 most recent publications (2020-2025) span stroke care economics, dysphagia management, and autonomic testing innovations, reflecting his commitment to clinical-neurological research infrastructure development. Scientific Awards : Metric-based scholarship for Austro-Mir space research Fellow of the European Academy of Neurology (FEAN)

• Neurodegeneration
• Parkinson’s Disease
• Glia
• +۷ مورد دیگر

Dr. Yuhong Fu is a Senior Research Fellow at the School of Medical Sciences , The University of Sydney , and a member of the Brain and Mind Centre . With a background in neurology and neuroscience, Fu's research focuses on glial involvement in neurodegeneration, particularly in Parkinson’s disease (PD) and related synucleinopathies. Education : MD (1996), PhD in Neuroscience (2002) on experimental autoimmune encephalomyelitis. Research Interests include: Glia in neurodegenerative diseases Alpha-synuclein pathology Lipid metabolism in PD and MSA Neuroanatomy and neuropathology Adult neurogenesis and neurorestoration Key Publications highlight astroglial protein profiles, lipid dysregulation, and glial-neuronal interactions in synucleinopathies. Recent work explores proximity ligation assays for early alpha-synuclein detection and sex-specific lipid changes in Abca7 knockout models. Scientific Awards : IDSA Foundation grant (2025) for bacterial traces in Alzheimer’s brains Michael J Fox Foundation support (2019) for glial protein studies in PD NHMRC grants (2018, 2017) for imaging platforms and mitophagy research Teaching & Supervision focuses on neuroanatomy and neurodegeneration. Current research students include Zirui Cao (Postmortem PD neural activity), Yang Liu (PD-associated genes pathobiology), and Zirui Zeng (Sleep neuron neuropathology in PD). Labs & Collaborations : Fu has worked with Neuroscience Research Australia (Paxinos’ and Halliday’s labs) and employs histology, microscopy, animal models, and molecular biology to study neurodegenerative mechanisms.

Miriam Sklerovمشاهده پروفایل

دانشیار

• Atypical Parkinsonism syndromes
• Movement disorders
• Neurodegenerative diseases
• +۳ مورد دیگر

Miriam Sklerov, MD, MSc, is an Associate Professor in the Department of Neurology at the University of North Carolina at Chapel Hill. She serves as Director of the UNC Atypical Parkinsonism Center, UNC CurePSP Center of Care, UNC MSA Center of Excellence, and the Autonomic Laboratory. Education: Doctor of Medicine (MD) from New York Medical College Master of Science in Epidemiology (MSc) from Columbia University Sklerov specializes in atypical parkinsonism syndromes (multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration) and movement disorders , with a focus on autonomic dysfunction and neuroimaging of central autonomic networks. Her research explores biomarker development for differential diagnosis of Parkinson's disease and neurodegenerative atypical parkinsonism. Recent publications highlight trends in biomarker panels for neurodegenerative diseases, α-synuclein analysis in exosomes, and hypothalamic connectivity disruptions. Notable collaborations span institutions including Columbia University Medical Center and University of North Carolina. Laboratory Leadership: Director, UNC Autonomic Laboratory

Phillip A. Lowمشاهده پروفایل

استاد

• Multiple System Atrophy
• Autonomic Neuropathies
• Orthostatic Hypotension
• +۳ مورد دیگر

Phillip A. Low, M.D. is a Professor of Neurology and Consultant in the Department of Neurology at Mayo Clinic in Rochester, Minnesota. He holds the Robert D. and Patricia E. Kern Professorship of Neurology. His research focuses on autonomic disorders, particularly multiple system atrophy (MSA), autonomic neuropathies, and orthostatic hypotension. He leads NIH-funded programs addressing MSA mechanisms and treatments, including clinical trials with rifampicin and mesenchymal stem cells. He developed the quantitative sudomotor axon reflex test (QSART) and pioneered diagnostic approaches for autonomic dysfunction. Education: MD: University of Sydney (1976) Residency: Royal Prince Alfred Hospital (1973), St. Vincent's Hospital (1967) Postdoctoral Fellowships: Dr. Tosio Narahashi (Northwestern University), Dr. P.J. Dyck (Mayo Clinic) Research Interests: Dr. Low’s work spans three core areas: (1) MSA pathogenesis and treatment, (2) novel autonomic diagnostic tests, and (3) autonomic neuropathies like diabetic and autoimmune forms. His team explores therapies to mitigate neuronal degeneration and improve autonomic function in patients. Grants & Projects: NIH-funded program project on MSA (2015–2025) Midodrine clinical benefit study (1998–1999) Menstrual cycle and orthostatic tolerance research (1998–2002) Awards: Jacob Javits Neuroscience Award (1988) Peter Bancroft Prize for Research (1976) Labs/Teams: His work is conducted within Mayo Clinic’s Autonomic Physiology and Neurophysiology Core, collaborating with interdisciplinary teams to advance synucleinopathy research and clinical trials.

• Neurodegenerative Diseases
• Parkinson's Disease
• Multiple System Atrophy
• +۵ مورد دیگر

Wouter Peelaerts serves as a Tenure Track Assistant Professor in the Department of Pharmaceutical and Pharmacological Sciences at KU Leuven's Faculty of Pharmaceutical Sciences. He holds cross-institute appointments at the ADVANTAGE research group (Advanced Disease Modelling, Targeted Drug Discovery and Gene Therapy), KU Leuven Brain Institute (LBI), Institute for Rare Diseases (Leuven.IRD), and Institute for Single Cell Omics (LISCO), while participating in faculty and departmental councils as senior academic staff. His research centers on neurodegenerative mechanisms in Parkinson's disease and multiple system atrophy (MSA), with emphasis on α-synuclein pathology propagation, oligodendrocyte dysfunction, and infection-triggered neurodegeneration. Key investigations explore how urinary tract infections initiate synucleinopathy via innate immune responses and how α-synuclein strain variations dictate disease phenotypes. His work integrates gene therapy approaches and small-molecule drug discovery targeting neuroinflammatory pathways. Analysis of his 2020-2024 publications reveals consistent focus on experimental models (iPSCs, organoids, rodent systems) to dissect α-synuclein transmission mechanisms. Dominant themes include strain-specific pathology in synucleinopathies, oligodendroglial contributions to MSA severity, and peripheral infection as a catalyst for central nervous system degeneration. Methodologically, his work bridges molecular neuropathology with translational immunology. Peelaerts leads or co-leads ten active research projects funded through 2027, including investigations into α-synuclein modulators for Parkinson's disease, oligodendrocyte roles in neurodegeneration models, and urinary tract infection-triggered synucleinopathy. His grant portfolio demonstrates sustained focus on infection-neurodegeneration links and oligodendroglial mechanisms across multiple system atrophy subtypes. Within the ADVANTAGE research group, he collaborates across KU Leuven's neuroscience ecosystem, leveraging resources from the Brain Institute, Rare Diseases Institute, and Single Cell Omics Institute to develop integrated models of proteinopathy and neuroinflammation. His team utilizes cutting-edge technologies including viral vector delivery systems and single-cell functional profiling for mechanistic studies.

Nadia Stefanovaمشاهده پروفایل

استاد

• Neurodegeneration
• Parkinson's Disease
• Multiple System Atrophy
• +۲ مورد دیگر

Nadia Stefanova is a Professor for Translational Neurodegeneration Research at the Medical University of Innsbruck, where she heads the Laboratory for Translational Neurodegeneration Research. She earned her medical degree in Sofia, Bulgaria, and joined the Department of Neurology in Innsbruck in 1999 through a PhD fellowship program, later completing her habilitation there. Her research focuses on fundamental molecular mechanisms underlying Parkinson's disease and multiple system atrophy (MSA), with emphasis on biomarker discovery and novel therapeutic development. Key areas include neurodegeneration pathways, protein aggregation, and translational neuroscience.

Johannes Levinمشاهده پروفایل

استاد

• Parkinson's Disease
• Alzheimer's Disease
• Movement Disorders
• +۳ مورد دیگر

Prof. Johannes Levin is a Professor of Clinical Neurodegeneration and Head of the Outpatient Clinics for Cognitive Neurology and Movement Disorders at the LMU Munich Neurological Clinic. He specializes in Parkinson's disease, Alzheimer's disease, and neurological intensive care. His clinical qualifications include Neurology specialist certification, Neurological Intensive Care Medicine, genetic counseling in Neurology, EEG certification, and Botulinum Toxin Therapy certification. Research focuses on synucleinopathies (Parkinson's/Multiple System Atrophy), tauopathies (Progressive Supranuclear Palsy/Corticobasal Syndrome), Alzheimer's pathology (especially genetic forms), and developing disease-modifying therapies. Key initiatives include the Early Clinical Trial Unit (ECTU), Neurology Winter School (NWS), and collaborative research networks like the Dominantly Inherited Alzheimer Network. Publications span biomarker development, drug trials (e.g., anle138b), and clinical diagnostic criteria for neurodegenerative disorders. His work bridges clinical practice with translational research, emphasizing early intervention and precision medicine approaches.

Chi-Ying Linمشاهده پروفایل

استادیار

• Alzheimer's Disease
• Cerebellar Ataxia
• Dementia
• +۷ مورد دیگر

Chi-Ying Lin is an Assistant Professor of Neurology at Baylor College of Medicine, specializing in movement disorders and neurodegenerative diseases. He leads the CurePSP Center of Care for Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Multiple System Atrophy (MSA) within the Parkinson's Disease Center and Movement Disorders Clinic. His clinical roles include managing Alzheimer's disease, dementia, and cerebellar ataxia cases at Baylor College of Medicine Medical Center in Houston, Texas. Dr. Lin holds an MD from Kaohsiung Medical University (Taiwan) and an MPH from Columbia University. His postgraduate training includes a neurology residency and movement disorders fellowship at Mount Sinai Health System, as well as postdoctoral research at Columbia University and Taipei Veterans General Hospital. He has extensive experience in cerebellar pathology and synaptic dysfunction research, particularly in essential tremor and neurodegenerative diseases. His research focuses on cerebellar contributions to cognitive and behavioral functions, including impulsivity in ataxias, cerebellar reward mechanisms, and the role of the cerebellum in Alzheimer's disease progression. He has also explored vascular risk factors in spinocerebellar ataxias and the non-motor symptoms of neurodegenerative disorders. His work bridges clinical care and translational research, emphasizing patient-centered outcomes and improving diagnostic approaches. Dr. Lin has been recognized with awards such as the Junior Faculty Seed Award (Baylor College of Medicine) and the Parkinson's Progression Markers Initiative WNI Award. He actively contributes to professional societies like the American Academy of Neurology and the International Parkinson and Movement Disorder Society.

• Neurodegenerative Diseases
• Alpha-Synuclein Pathology
• Electron Microscopy Techniques
• +۳ مورد دیگر

Roles & Affiliation: Domenic Burger is a current member of EPFL affiliated with the LBEM (Laboratory) unit, focusing on structural biology and neurodegenerative diseases. His research combines advanced microscopy techniques with molecular pathology analysis. Education: Holds a Doctoral degree from EPFL, as reflected in his thesis titled 'Disentangling Multiple System Atrophy' (2024). Research Interests: Specializes in alpha-synuclein fibril structures, mechanisms of Multiple System Atrophy (MSA), and correlative light-electron microscopy (CLEM). His work bridges ultrastructural analysis with disease progression studies, particularly in neurological disorders. Publications: Recent work includes advancements in CLEM protocols for human brain tissue and high-resolution structural analysis of synthetic α-synuclein fibrils. These studies explore fibril transmission in animal models and their implications for prion-like disease mechanisms. Awards & Grants: No specific awards mentioned, but research is supported by institutions like the Swiss National Science Foundation and EMBO. Advising & Labs: Works within the LBEM unit at EPFL, collaborating with teams such as Chimie et Biologie des Membranes et des Nanoobjects. His lab focuses on integrating cryo-EM and correlative microscopy to study neurodegenerative pathology.

Meredith Bryarlyمشاهده پروفایل

استاد بالینی

• Autonomic Disorders
• Neuromuscular Medicine
• Postural Tachycardia Syndrome (POTS)
• +۳ مورد دیگر

Meredith Bryarly is a Clinical Professor at the University of Texas Southwestern Medical Center, Department of Neurology. She joined the faculty in 2016 and specializes in autonomic and neuromuscular disorders. She founded and directs the Autonomic Disorders Clinic at the Dallas VA and participates in the Multiple System Atrophy (MSA) Clinic at UT Southwestern. Her clinical expertise includes autonomic studies, nerve conduction studies, electromyography (EMG), and single-fiber EMG. Dr. Bryarly holds board certifications in Neurology (2015), Neuromuscular Medicine (2016), and Autonomic Disorders (2018). She completed her undergraduate studies at Yale University, earned her medical degree from UT Health Science Center in San Antonio, and underwent neurology residency and fellowships in neuromuscular and autonomic disorders at UT Southwestern. Her research focuses on postural tachycardia syndrome (POTS), orthostatic hypotension (OH), and MSA, leading clinical trials in autonomic disorders. She also contributes to medical education as the Associate Clerkship Director for the UT Southwestern Neurology Clerkship and participates in medical school committees. Dr. Bryarly is actively involved in professional associations, including the 2019 UCNS subspecialty program task force. Her work emphasizes advancing clinical care, diagnostic tools, and therapeutic strategies for autonomic and neuromuscular diseases.

Jacob Ayersمشاهده پروفایل

دانشیار

• Prion Diseases
• Neurodegeneration
• Protein Misfolding
• +۲ مورد دیگر

Jacob Ayers is Associate Adjunct Professor at the UCSF Institute for Neurodegenerative Diseases, where his research investigates protein misfolding mechanisms in prion diseases and related neurodegenerative disorders. Core research examines: 1) Prion-like propagation of misfolded proteins in ALS and related disorders; 2) Strain-specific pathology in tauopathies and synucleinopathies; and 3) Transgenic model development for neurodegenerative disease research. His laboratory employs molecular, cellular, and in vivo approaches to understand disease transmission mechanisms. Recent work establishes distinct prion strains for α-synuclein pathology in dementia with Lewy bodies versus multiple system atrophy. Publications also characterize tau prion transmission in novel rodent models and identify RNA-binding properties of pathological tau aggregates.

Paola Sandroniمشاهده پروفایل

استاد

• Autonomic Disorders
• Neuropathic Pain
• Erythromelalgia
• +۴ مورد دیگر

Paola Sandroni is a Professor of Neurology and Chair of the Department of Neurology at Mayo Clinic. She leads the Section of Autonomic Neurology and is affiliated with Mayo's Clinical Research and Trials Unit. Her work focuses on autonomic disorders, neuropathic pain, and erythromelalgia, collaborating with interdisciplinary teams across institutions like the University of Minnesota and the Autonomic Physiology/Neurophysiology Facility. Education: M.D. and Ph.D. in Neuroscience, Università di Milano Fellowships and residencies at Mayo Clinic in Neurology, Neuromuscular Disorders, and Internal Medicine Research Interests: Characterizing autonomic disorders (e.g., pure autonomic failure, postural tachycardia syndrome) Evaluating therapeutic strategies for neuropathic pain and erythromelalgia Investigating autonomic nervous system interactions with vestibular systems and vascular pathologies Collaborations: Active partnerships with Michael Camilleri, Michael J. Joyner, Phillip A. Low, and William R. Kennedy on autonomic physiology and clinical trials. Leads trials for neuropathic pain and innovative treatments like brain magnetic stimulation. Labs/Teams: Principal investigator in the Autonomic Physiology/Neurophysiology Facility and Clinical Trials Unit at Mayo Clinic.

• Neurodegenerative Diseases
• Movement Disorders
• Neurology
• +۳ مورد دیگر

Maria Stamelou is a Visiting Associate Professor in Neurology at the School of Medicine, European University of Cyprus. She holds academic qualifications including an Apl. Professor title from Philipps University, Marburg, Germany (2017), and a PhD in Neurology (2009) from the same institution. Her career includes roles as Principal Investigator in multiple neurology-related clinical trials and editorial leadership at the Movement Disorders Journal. Her research focuses on neurodegenerative diseases, particularly Parkinsonian syndromes like Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). Key interests include clinical diagnosis criteria validation, neuroprotection strategies, and genetic Parkinsonism. Her work emphasizes translating pathological insights into clinical practice through biomarker development and trial design. Dr. Stamelou has led high-impact studies published in Lancet Neurology and Mov Disord , addressing diagnostic challenges and therapeutic targets. She has received prestigious awards including the L’Oreal-UNESCO Women in Science Award (2019) and Fellowship from the European Academy of Neurology (since 2015). Her research projects include global initiatives like the Parkinson's Progression Markers Initiative (PPMI). Her advisory roles include editorial duties for the Movement Disorders Journal and leadership in clinical trial networks. She has conducted over 12 clinical trials in Parkinson’s and PSP, demonstrating expertise in both basic science and translational research.

Thomas Klockgetherمشاهده پروفایل

استاد

• Neuropharmacology of Parkinson's disease
• Brain imaging
• Clinical neurology of ataxias
• +۴ مورد دیگر

Thomas Klockgether is Professor of Neurology and Clinical Director of the Department of Neurology at the University of Bonn , Germany. Since 2011 he also serves as Director of Clinical Research at the German Center for Neurodegenerative Diseases (DZNE) . From 2008 to 2011 he was Dean of the Medical Faculty, University of Bonn, and since 2010 he has been Speaker of the Center for Rare Diseases Bonn (ZSEB) . Education & Training: 1974–1980: Medical studies, University of Göttingen 1980–1983: Clinical training in internal medicine and anaesthesiology, Oldenburg 1987–1991: Neurology residency, University of Tübingen; board certification in neurology (1991) Research Focus: Prof. Klockgether’s research integrates clinical neurology, neurogenetics, neuropharmacology and advanced brain imaging to unravel the mechanisms of Parkinson’s disease and degenerative ataxias . Early work at the Max Planck Institute elucidated glutamatergic mechanisms in Parkinson’s disease and the mode of action of amantadine. Over the past two decades his laboratory has concentrated on: Natural history and biomarker discovery in spinocerebellar ataxias (SCA1, 2, 3, 6) Molecular genetics and pathogenesis of SCAs and multiple system atrophy Development and validation of the SARA (Scale for Assessment and Rating of Ataxia) clinical scale International therapy development platforms such as EUROSCA , RISCA , ESMI and the Ataxia Global Initiative (AGI) launched in 2018 Scientific Awards & Distinctions: Attempto-Prize, University of Tübingen (1991) Schilling Professorship, Stifterverband (1993) Award of the German Heredoataxia Society (1994) Holmes Prize, Fondation de l’Ataxie cérébelleuse (1999) Guest Professorship, Central South University, China (2007) Honorary Member, German Heredoataxia Society (2013) Leadership & Collaborative Networks: As Speaker of the Center for Rare Diseases Bonn (ZSEB) and Director of Clinical Research at DZNE , Prof. Klockgether coordinates multicentre longitudinal cohort studies, biomarker consortia and early-phase therapeutic trials. He founded the Ataxia Global Initiative (AGI) in 2018 and chairs its international steering committee, uniting academic centres, industry and patient organisations worldwide to accelerate therapy development for ataxias.